Migraine

Latest News

OTC Products, Oral Prescriptions Demonstrate Efficacy in Episodic Migraine
OTC Products, Oral Prescriptions Demonstrate Efficacy in Episodic Migraine

September 19th 2023

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

Pfizer's New Migraine Treatment Now Available in US Pharmacies: What You Need to Know
Pfizer's New Migraine Treatment Now Available in US Pharmacies: What You Need to Know

July 28th 2023

Intranasal CGRP Antagonist Is Approved for the Treatment of Acute Migraines
Intranasal CGRP Antagonist Is Approved for the Treatment of Acute Migraines

July 20th 2023

CGRP Inhibitors Significantly Reduce Disability in Migraine
CGRP Inhibitors Significantly Reduce Disability in Migraine

June 12th 2023

Ketamine Nasal Spray May Help Treat Refractory Chronic Migraines
Ketamine Nasal Spray May Help Treat Refractory Chronic Migraines

June 2nd 2023

Latest CME Events & Activities

Individualizing the Management of Primary Immunodeficiency Disorders: Considerations in the Selection of Intravenous Immunoglobulin or Subcutaneous Immunoglobulin

2.0 Credits / Immunology, Neurology

View More

Exploring Primary Immunodeficiency Disorder Treatment: A Review of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin Therapies

1.0 Credit / Immunology, Neurology

View More

AMCP Nexus 2023

View More

Challenges of Treating Epilepsy Syndromes and Opportunities in an Expanding Therapeutic Landscape: A Managed Care Perspective

1.5 Credits / Neurology

View More

Recognizing Rett Syndrome: Managed Care Insights on Disease Burden

1.5 Credits / Neurology, Rare Diseases

View More

Advancements in Myasthenia Gravis Treatment: Supporting Access Through Value-Based Care Models

1.5 Credits / Immunology, Neurology, Rare Diseases

View More

Oral Chemotherapy Parity Legislation: Opportunities for Cancer Care Equity

1.0 Credit / Law, Oncology

View More

Strategies to Improve the Management of Migraine: Clinical Updates for Pharmacists and Patient-Case Review

1.0 Credit / Neurology

View More

Therapeutic Strategies for Bipolar Disorder: Recognizing the Intricacies in Disease Management and Considerations for Pharmacists Across Practice Settings

2.0 Credits / Neurology, Psychiatry

View More

Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs

0.75 Credit / Neurology

View More

Treatment of ALS: Examining the Role of Current and Emerging Therapies

1.0 Credit / Neurology

View More

A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacy Technician Credit)

1.0 Credit / Neurology

View More

A Focus on New Therapies for ADHD: Expanding Treatment Options for Patients (Pharmacist Credit)

1.0 Credit / Neurology

View More

Managed Care Considerations for Parkinson Disease: A Focus on Recent Data and Emerging Therapies

1.0 Credit / Neurology

View More

A Supplement to the American Journal of Managed Care: Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care

2.0 Credits / Neurology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

1.0 Credit / Neurology, Psychiatry

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment

1.5 Credits / Neurology

View More

The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia

1.5 Credits / Neurology, Psychiatry

View More

The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights

1.0 Credit / Neurology

View More

Rare and Treatment-Resistant Epilepsy Syndromes: Identifying and Addressing the Unmet Needs of Patients and Recognizing Opportunities for Pharmacist Intervention

1.5 Credits / Neurology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention

3.0 Credits / Neurology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

More News

© 2023 MJH Life Sciences

All rights reserved.